Atea Pharmaceuticals, Inc.(AVIR)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

AVIR Atea Pharmaceuticals, Inc.

交易中 07-22 09:37:35 EDT

3.58

+0.01

+0.28%

最高3.61	最低3.57	成交量1,875
今开3.61	昨收3.57	日振幅1.12%
总市值3.02亿	流通市值2.31亿	总股本8,422万
成交额6,753	换手率0.00%	流通股本6,442万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"AVIR","market":"US","secType":"STK","nameCN":"Atea Pharmaceuticals, Inc.","latestPrice":3.58,"timestamp":1721655293268,"preClose":3.57,"halted":0,"volume":1875,"delay":0,"floatShares":64420859,"shares":84223100,"eps":-1.959138,"marketStatus":"交易中","marketStatusCode":2,"change":0.01,"latestTime":"07-22 09:37:35 EDT","open":3.61,"high":3.61,"low":3.57,"amount":6752.6086875,"amplitude":0.011204,"askPrice":3.63,"askSize":200,"bidPrice":3.58,"bidSize":328,"shortable":3,"etf":0,"ttmEps":-1.959138,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1721678400000},"adr":0,"listingDate":1604030400000,"adjPreClose":3.57,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":3.57,"preClose":3.57,"latestTime":"16:02 EDT","volume":3104,"amount":11081.28,"timestamp":1721419331308},"volumeRatio":0.426546,"impliedVol":1.7689,"impliedVolPercentile":0.8486},"requestUrl":"/m/hq/s/AVIR/tweets","defaultTab":"tweets","newsList":[{"id":"2452538104","title":"Atea Pharmaceuticals, Inc.盘中异动 下午盘股价大跌5.17%报3.67美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452538104","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452538104?lang=zh_cn&edition=full","pubTime":"2024-07-19 02:39","pubTimestamp":1721327958,"startTime":"0","endTime":"0","summary":"北京时间2024年07月19日02时39分，Atea Pharmaceuticals, Inc.股票出现异动，股价急速下挫5.17%。Atea Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为1.77%。其相关个股中，Onconetix, Inc.、Silo Pharma, Inc.、Salarius Pharmaceuticals, Inc.涨幅较大，Salarius Pharmaceuticals, Inc.、Silo Pharma, Inc.、Onconetix, Inc.较为活跃，换手率分别为3234.58%、2596.46%、1302.40%，振幅较大的相关个股有Silo Pharma, Inc.、Salarius Pharmaceuticals, Inc.、Onconetix, Inc.，振幅分别为93.33%、91.50%、86.24%。Atea Pharmaceuticals, Inc.公司简介：Atea Pharmaceuticals Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化抗病毒疗法，以改善患有严重病毒感染的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240719023918af9301e8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240719023918af9301e8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","AVIR"],"gpt_icon":0},{"id":"2451919228","title":"Atea Pharmaceuticals, Inc.盘中异动 早盘快速拉升5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2451919228","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451919228?lang=zh_cn&edition=full","pubTime":"2024-07-16 23:13","pubTimestamp":1721142804,"startTime":"0","endTime":"0","summary":"北京时间2024年07月16日23时13分，Atea Pharmaceuticals, Inc.股票出现波动，股价大幅拉升5.05%。Atea Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.35%。Atea Pharmaceuticals, Inc.公司简介：Atea Pharmaceuticals Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化抗病毒疗法，以改善患有严重病毒感染的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240716231324aef9f729&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240716231324aef9f729&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AVIR","BK4007"],"gpt_icon":0},{"id":"2450655083","title":"Atea Pharmaceuticals, Inc.盘中异动 股价大涨5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450655083","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450655083?lang=zh_cn&edition=full","pubTime":"2024-07-11 22:01","pubTimestamp":1720706467,"startTime":"0","endTime":"0","summary":"北京时间2024年07月11日22时01分，Atea Pharmaceuticals, Inc.股票出现异动，股价快速拉升5.05%。Atea Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.84%。Atea Pharmaceuticals, Inc.公司简介：Atea Pharmaceuticals Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化抗病毒疗法，以改善患有严重病毒感染的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711220108aef93e51&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240711220108aef93e51&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","AVIR"],"gpt_icon":0},{"id":"2445508987","title":"Atea Pharmaceuticals, Inc.盘中异动 早盘大幅上涨5.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2445508987","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445508987?lang=zh_cn&edition=full","pubTime":"2024-06-21 21:31","pubTimestamp":1718976666,"startTime":"0","endTime":"0","summary":"北京时间2024年06月21日21时31分，Atea Pharmaceuticals, Inc.股票出现波动，股价快速上涨5.26%。Atea Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.27%。Atea Pharmaceuticals, Inc.公司简介：Atea Pharmaceuticals Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化抗病毒疗法，以改善患有严重病毒感染的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240621213106af8ea646&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240621213106af8ea646&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","AVIR"],"gpt_icon":0},{"id":"2441270210","title":"Atea Pharmaceuticals, Inc.盘中异动 快速拉升5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2441270210","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2441270210?lang=zh_cn&edition=full","pubTime":"2024-06-05 22:46","pubTimestamp":1717598774,"startTime":"0","endTime":"0","summary":"北京时间2024年06月05日22时46分，Atea Pharmaceuticals, Inc.股票出现异动，股价大幅拉升5.04%。Atea Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.96%。Atea Pharmaceuticals, Inc.公司简介：Atea Pharmaceuticals Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化抗病毒疗法，以改善患有严重病毒感染的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240605224615aef39187&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240605224615aef39187&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","AVIR"],"gpt_icon":0},{"id":"2440940774","title":"Atea Pharmaceuticals, Inc.盘中异动 快速上涨5.18%报3.86美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2440940774","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2440940774?lang=zh_cn&edition=full","pubTime":"2024-06-03 23:13","pubTimestamp":1717427581,"startTime":"0","endTime":"0","summary":"北京时间2024年06月03日23时13分，Atea Pharmaceuticals, Inc.股票出现异动，股价大幅上涨5.18%。截至发稿，该股报3.86美元/股，成交量12.4354万股，换手率0.15%，振幅5.65%。Atea Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.63%。Atea Pharmaceuticals, Inc.公司简介：Atea Pharmaceuticals Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化抗病毒疗法，以改善患有严重病毒感染的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240603231302af8bb801&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240603231302af8bb801&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","AVIR"],"gpt_icon":0},{"id":"2437600291","title":"Atea Pharmaceuticals, Inc.盘中异动 股价大涨5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2437600291","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2437600291?lang=zh_cn&edition=full","pubTime":"2024-05-22 22:15","pubTimestamp":1716387357,"startTime":"0","endTime":"0","summary":"北京时间2024年05月22日22时15分，Atea Pharmaceuticals, Inc.股票出现波动，股价急速拉升5.12%。Atea Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.23%。Atea Pharmaceuticals, Inc.公司简介：Atea Pharmaceuticals Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化抗病毒疗法，以改善患有严重病毒感染的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240522221557aef11907&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240522221557aef11907&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","AVIR"],"gpt_icon":0},{"id":"2436719333","title":"Atea Pharmaceuticals, Inc.2024财年第一财季实现净利润-63.17百万美元，同比减少78.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2436719333","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2436719333?lang=zh_cn&edition=full","pubTime":"2024-05-20 00:08","pubTimestamp":1716134909,"startTime":"0","endTime":"0","summary":"3月31日，Atea Pharmaceuticals, Inc.公布财报，公告显示公司2024财年第一财季净利润为-63.17百万美元，同比减少78.09%；其中营业收入为0.00美元，每股基本收益为-0.75美元。机构评级：截至2024年3月31日，当前有2家机构对Atea Pharmaceuticals, Inc.目标价做出预测，其中目标均价为3.00美元，其中最低目标价为2.00美元，最高目标价为4.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240520000831877ab228&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240520000831877ab228&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AVIR"],"gpt_icon":0},{"id":"2435888786","title":"美国研究综述-Altus Power、Jack in the Box、Home Depot","url":"https://stock-news.laohu8.com/highlight/detail?id=2435888786","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435888786?lang=zh_cn&edition=full","pubTime":"2024-05-15 15:18","pubTimestamp":1715757518,"startTime":"0","endTime":"0","summary":"    路透5月15日 - 华尔街证券分析师周三调整了对几家美国上市公司的评级和目标价，其中包括 Altus Power、Jack in the Box 和 Home Depot。* Jack in the Box Inc   ：Wedbush将目标价从78美元下调至68美元 * Home Depot Inc   ：TD Cowen将目标价从440美元下调至420美元 以下是路透周三报导的美国公司研究行动摘要。* Altus Power Inc   ：摩根大通将其评级从 \"增持 \"下调至 \"中性\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4150","LU1093756168.USD","ANNX","IE00BSNM7G36.USD","PHUN","ANAB","BK4585","LU0868494617.USD","BK4504","NUVL","BK4534","IGT","RLYB","AMPS","BOLT","BK4185","PACS","SG9999001440.SGD","PGNY","VECO","HROW","LU1496350502.SGD","BK4539","IE00BZ1G4Q59.USD","LU1989772923.USD","BK4023","LU1989772840.SGD","BK4154","SDHC","BK4139","BK4133","BK4083","HQI","LQDA","LU0823411888.USD","CRIS","BK4088","IE00BWXC8680.SGD","BK4533","IE0031619046.USD","BK4581","OXY","JACK","LU0820562030.AUD","AVIR","IE00B66KJ199.SGD","BK4588","HLVX","HD","BK4130"],"gpt_icon":0},{"id":"2435820688","title":"美国研究综述-Altus Power、Jack in the Box、Home Depot","url":"https://stock-news.laohu8.com/highlight/detail?id=2435820688","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2435820688?lang=zh_cn&edition=full","pubTime":"2024-05-15 15:18","pubTimestamp":1715757518,"startTime":"0","endTime":"0","summary":"    路透5月15日 - 华尔街证券分析师周三调整了对几家美国上市公司的评级和目标价，其中包括 Altus Power、Jack in the Box 和 Home Depot。* Jack in the Box Inc   ：Wedbush将目标价从78美元下调至68美元 * Home Depot Inc   ：TD Cowen将目标价从440美元下调至420美元 以下是路透周三报道的美国公司研究行动摘要。* Altus Power Inc   ：摩根大通将其评级从 \"增持 \"下调至 \"中性\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","LU0820562030.AUD","BK4588","LU1989772840.SGD","LU1093756168.USD","SDHC","BK4585","LU0823411888.USD","LU1496350502.SGD","BK4083","RLYB","JACK","LQDA","ANAB","IGT","AMPS","CRIS","AVIR","PGNY","HROW","HD","VECO","BK4154","BK4130","IE00BZ1G4Q59.USD","IE00BWXC8680.SGD","BK4133","SG9999001440.SGD","BK4185","BK4533","BK4581","IE00BSNM7G36.USD","IE0031619046.USD","BOLT","BK4539","ANNX","HLVX","BK4150","HQI","NUVL","BK4504","BK4088","OXY","BK4139","LU1989772923.USD","PACS","IE00B66KJ199.SGD","PHUN","BK4023","LU0868494617.USD"],"gpt_icon":0},{"id":"2432973275","title":"Atea Pharmaceuticals Inc    预计每股亏损 61 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2432973275","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2432973275?lang=zh_cn&edition=full","pubTime":"2024-05-03 19:47","pubTimestamp":1714736860,"startTime":"0","endTime":"0","summary":"   * Atea Pharmaceuticals Inc    预计在5月6日公布截至2024年3月31日的业绩时，季度收入将没有变化(预计)。*    * LSEG的分析师平均预计Atea Pharmaceuticals Inc每股亏损61美分。* 华尔街对 Atea Pharmaceuticals Inc 的 12 个月目标价中位数为 3.50 美元，低于其最新收盘价 3.83 美元。5月3日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVIR"],"gpt_icon":0},{"id":"2432508430","title":"Atea Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2432508430","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2432508430?lang=zh_cn&edition=full","pubTime":"2024-05-01 21:59","pubTimestamp":1714571943,"startTime":"0","endTime":"0","summary":"北京时间2024年05月01日21时59分，Atea Pharmaceuticals, Inc.股票出现异动，股价急速上涨5.41%。Atea Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.19%。Atea Pharmaceuticals, Inc.公司简介：Atea Pharmaceuticals Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化抗病毒疗法，以改善患有严重病毒感染的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405012159037925a161&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405012159037925a161&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AVIR","BK4007"],"gpt_icon":0},{"id":"2422990915","title":"Atea Pharmaceuticals, Inc.盘中异动 急速上涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422990915","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2422990915?lang=zh_cn&edition=full","pubTime":"2024-03-27 21:39","pubTimestamp":1711546750,"startTime":"0","endTime":"0","summary":"北京时间2024年03月27日21时39分，Atea Pharmaceuticals, Inc.股票出现波动，股价大幅拉升5.04%。Atea Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.18%。Atea Pharmaceuticals, Inc.公司简介：Atea Pharmaceuticals Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化抗病毒疗法，以改善患有严重病毒感染的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403272139107a4f8795&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403272139107a4f8795&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AVIR","BK4007"],"gpt_icon":0},{"id":"2420747725","title":"Atea Pharmaceuticals, Inc.盘中异动 早盘大幅下跌5.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2420747725","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2420747725?lang=zh_cn&edition=full","pubTime":"2024-03-20 21:31","pubTimestamp":1710941477,"startTime":"0","endTime":"0","summary":"北京时间2024年03月20日21时31分，Atea Pharmaceuticals, Inc.股票出现异动，股价急速下跌5.84%。Atea Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.41%。Atea Pharmaceuticals, Inc.公司简介：Atea Pharmaceuticals Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化抗病毒疗法，以改善患有严重病毒感染的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240320213117879d61c5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240320213117879d61c5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AVIR","BK4007"],"gpt_icon":0},{"id":"2416302140","title":"Atea Pharmaceuticals, Inc.盘中异动 股价大跌5.06%报4.23美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2416302140","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2416302140?lang=zh_cn&edition=full","pubTime":"2024-03-04 23:06","pubTimestamp":1709564773,"startTime":"0","endTime":"0","summary":"北京时间2024年03月04日23时06分，Atea Pharmaceuticals, Inc.股票出现波动，股价快速下挫5.06%。截至发稿，该股报4.23美元/股，成交量2.8392万股，换手率0.03%，振幅5.62%。Atea Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.06%。Atea Pharmaceuticals, Inc.公司简介：Atea Pharmaceuticals Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化抗病毒疗法，以改善患有严重病毒感染的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030423061379171adc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030423061379171adc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AVIR","BK4007"],"gpt_icon":0},{"id":"2416909550","title":"Atea Pharmaceuticals, Inc.2023财年实现净利润-1.36亿美元，同比减少17.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2416909550","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2416909550?lang=zh_cn&edition=full","pubTime":"2024-03-04 00:27","pubTimestamp":1709483225,"startTime":"0","endTime":"0","summary":"12月31日，Atea Pharmaceuticals, Inc.公布财报，公告显示公司2023财年净利润为-1.36亿美元，同比减少17.24%；其中营业收入为0.00美元，每股基本收益为-1.63美元。机构评级：截至2023年12月31日，当前有2家机构对Atea Pharmaceuticals, Inc.目标价做出预测，其中目标均价为3.50美元，其中最低目标价为2.00美元，最高目标价为5.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030400271487e0e72b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030400271487e0e72b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AVIR"],"gpt_icon":0},{"id":"2416786629","title":"Atea Pharmaceuticals, Inc.盘中异动 急速拉升5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2416786629","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2416786629?lang=zh_cn&edition=full","pubTime":"2024-03-02 01:03","pubTimestamp":1709312594,"startTime":"0","endTime":"0","summary":"北京时间2024年03月02日01时03分，Atea Pharmaceuticals, Inc.股票出现波动，股价快速上涨5.10%。Atea Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为2.58%。Atea Pharmaceuticals, Inc.公司简介：Atea Pharmaceuticals Inc 是一家临床阶段的生物制药公司，专注于发现、开发和商业化抗病毒疗法，以改善患有严重病毒感染的患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030201031479166597&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024030201031479166597&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AVIR","BK4007"],"gpt_icon":0},{"id":"2415541152","title":"美国研究综述-Inhibrx、LSB Industries、Xencor","url":"https://stock-news.laohu8.com/highlight/detail?id=2415541152","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2415541152?lang=zh_cn&edition=full","pubTime":"2024-02-29 20:56","pubTimestamp":1709211391,"startTime":"0","endTime":"0","summary":"    路透社2月29日 - 华尔街证券分析师周四调整了对几家美国上市公司的评级和目标价，其中包括 Inhibrx、LSB Industries 和 Xencor。* Inhibrx Inc   ：杰富瑞将其评级从 \"买入 \"下调至 \"持有 * LSB Industries Inc   ：Piper Sandler将其评级从 \"中性 \"下调至 \"减持\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4154","AVDX","ALKT","AMRC","APA","AAP","DIBS","BK4185","AMH","ACHC","BK4187","ACLX","BK4224","BYND","BCSF","BRP","LU0266013472.USD","BE","AMP","BK4543","AGL","AI","SAM","ARRY","AZO","LU0965509101.SGD","AXON","COLD","BGS","APG","IE00BZ1G4Q59.USD","BXSL","INBX","BAND","ALHC","ARVN","ADP","ACMR","AEO","LU0234570918.USD","ASPI","BBDC","BK4182","BKNG","ARKO","AVIR","MITT","ABNB","ATSG","BK4089"],"gpt_icon":0},{"id":"2415056730","title":"美国研究综述-Okta、Salesforce、Sarepta Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2415056730","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2415056730?lang=zh_cn&edition=full","pubTime":"2024-02-29 15:07","pubTimestamp":1709190420,"startTime":"0","endTime":"0","summary":"    路透社2月29日 - 华尔街证券分析师周四调整了对几家美国上市公司的评级和目标价，其中包括 Okta、Salesforce 和 Sarepta Therapeutics。要点             * Clearwater Analytics Holdings Inc   ：摩根大通将其评级从 \"增持 \"下调至 \"中性             * Okta Inc   ：Piper Sandler将目标价从85美元上调至110美元              * Salesforce Inc   ：巴克莱将目标价从325美元上调至355美元              * Sarepta Therapeutics Inc   ：Leerink Partners将目标价从145美元上调至165美元              * Universal Health Services Inc   ：Leerink Partners将目标价从174美元上调至192美元  以下是路透社周四报道的美国公司研究行动摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MNST","CWAN","SDGR","NARI","NTNX","PR","AAP","ALKT","SRPT","UHS","OKTA","DIN","AVIR","VCSA","CRWD","AVDX","RXST","PRKS","SILK","RVNC","CRM","SHLS","SHOO","MRSN","EDIT","ACHC","GPOR","ARRY","SLRC","MRVL","SNOW"],"gpt_icon":0},{"id":"2415556195","title":"Atea Pharmaceuticals Inc 报告截至 12 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2415556195","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2415556195?lang=zh_cn&edition=full","pubTime":"2024-02-29 10:27","pubTimestamp":1709173625,"startTime":"0","endTime":"0","summary":"   * Atea Pharmaceuticals Inc   报告，截至12月底的季度调整后每股亏损47美分，低于去年同期的每股收益-41美分。四位分析师对该季度的平均预期是每股亏损 50 美分。华尔街预期为每股-52美分至-48美分。* Atea Pharmaceuticals Inc 公布的季度每股收益为亏损 47 美分。* 该公司当季亏损 3,870 万美元。* Atea Pharmaceuticals Inc 的股价本季度上涨了 49.5%。华尔街对 Atea Pharmaceuticals Inc 的 12 个月目标价中位数为 3.00 美元。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AVIR","BK4007"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ateapharma.com","stockEarnings":[{"period":"1week","weight":0.0408},{"period":"1month","weight":0.0229},{"period":"3month","weight":-0.0403},{"period":"6month","weight":0},{"period":"1year","weight":-0.0299},{"period":"ytd","weight":0.1705}],"compareEarnings":[{"period":"1week","weight":-0.0196},{"period":"1month","weight":0.0009},{"period":"3month","weight":0.1087},{"period":"6month","weight":0.138},{"period":"1year","weight":0.2141},{"period":"ytd","weight":0.155}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Atea Pharmaceuticals, Inc.于2012年7月注册成立，并于2014年3月开始主要运营。该公司是一家临床阶段的生物制药公司，致力于发现，开发和商业化抗病毒治疗剂，以改善遭受威胁生命的病毒感染的患者的生活。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.218105},{"month":2,"riseRate":0.5,"avgChangeRate":-0.06977},{"month":3,"riseRate":0.25,"avgChangeRate":-0.039529},{"month":4,"riseRate":0,"avgChangeRate":-0.223714},{"month":5,"riseRate":0.5,"avgChangeRate":0.09522},{"month":6,"riseRate":0.25,"avgChangeRate":-0.051956},{"month":7,"riseRate":0.75,"avgChangeRate":0.079082},{"month":8,"riseRate":0.333333,"avgChangeRate":0.027042},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.056266},{"month":10,"riseRate":0.666667,"avgChangeRate":-0.176728},{"month":11,"riseRate":0.25,"avgChangeRate":-0.126274},{"month":12,"riseRate":1,"avgChangeRate":0.101156}],"exchange":"NASDAQ","name":"Atea Pharmaceuticals, Inc.","nameEN":"Atea Pharmaceuticals, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Atea Pharmaceuticals, Inc.(AVIR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Atea Pharmaceuticals, Inc.(AVIR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Atea Pharmaceuticals, Inc.,AVIR,Atea Pharmaceuticals, Inc.股票,Atea Pharmaceuticals, Inc.股票老虎,Atea Pharmaceuticals, Inc.股票老虎国际,Atea Pharmaceuticals, Inc.行情,Atea Pharmaceuticals, Inc.股票行情,Atea Pharmaceuticals, Inc.股价,Atea Pharmaceuticals, Inc.股市,Atea Pharmaceuticals, Inc.股票价格,Atea Pharmaceuticals, Inc.股票交易,Atea Pharmaceuticals, Inc.股票购买,Atea Pharmaceuticals, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Atea Pharmaceuticals, Inc.(AVIR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Atea Pharmaceuticals, Inc.(AVIR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}